Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

COBAN 60 PREMIX DIN 00423130

Status: Cancelled Post Market
Holder: ELANCO DIVISION ELI LILLY CANADA INC
Molecule: MONENSIN

Health Canada record

Active ingredient(s)MONENSIN 132.2 G
Dosage formDrug Premix
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date31-Dec-1979
Current status date24-Sep-1999
SourceHealth Canada DPD

Establishment licence of the holder

Elanco Division Eli Lilly Canada Inc — licence 101626, not currently licensed, last inspection rating C (2016-06-28).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MONENSIN

DINProductCompanyFormStrengthStatus
00690627RUMENSIN FEEDLOT PREMIX 1100 FMX 1100MG/KGUNIFEED LIMITEDDrug PremixMONENSIN 1.1 GCancelled Post Market
Request a quote for COBAN 60 PREMIX

How to read a Canadian DIN record